{
  "id": 12501878,
  "title": "Multiply Labs raises $75M to optimize pharmaceutical manufacturing with robots",
  "url": "https://urgent.news/2026/10/07/multiply-labs-raises-75m-to-optimize-pharmaceutical-manufacturing",
  "topic": "tech",
  "section": "Tech",
  "published": "2026-10-07T00:12:39.000Z",
  "source": {
    "name": "SiliconANGLE",
    "slug": "siliconangle",
    "url": "https://siliconangle.com/2026/10/06/multiply-labs-raises-75m-to-optimize-pharmaceutical-manufacturing-with-robots/"
  },
  "original_language": "en",
  "account": "Multiply Labs, a startup specializing in automation equipment for pharmaceutical manufacturers, has recently secured $75 million in funding. The Series B round of financing was led by renowned medical researcher Patrick Soon-Shiong, and brought in over a dozen additional investors, including industry giants AstraZeneca and Teradyne. The company's technology targets the repetitive and labor-intensive manufacturing processes in drug production, which typically require manual labor. Multiply Labs' invention, called robotics clusters, consist of specialized enclosures housing various pieces of manufacturing equipment, interconnected by robotic arms that transport materials between machines. These systems are notably lighter than traditional warehouse automation, making them easier to replace in case of malfunctions. They also feature tactile sensors to monitor the pressure applied to vials, ensuring precise alignment with manufacturing needs. The robots can carry out tasks such as stirring vials and mixing contents within containers, all guided by an AI model trained from data provided by their clientele. This means that drug manufacturers can switch to robotic workflows without needing new regulatory approval, as the process essentially remains unchanged. Currently, Multiply Labs is concentrating on automating the production of cell and gene therapies, personalized treatments that require patient-specific formulations. With the new investment, the company plans to broaden its support to other types of therapies and augment its manufacturing capacity.",
  "summary": "Multiply Labs Inc., a startup that develops automation equipment for drugmakers, has raised $75 million in funding. Prominent medical researcher Patrick Soon-Shiong led the deal. Multiply Labs stated in today’s funding announcement that the Series B raise also drew more than a half-dozen other backers. The group included AstraZeneca plc and Teradyne Inc., a robotics […] The post Multiply Labs…",
  "key_points": [
    "Multiply Labs raises $75M in Series B funding led by Patrick Soon-Shiong",
    "Robotics clusters automate repetitive pharmaceutical manufacturing processes",
    "Funds will expand support to other therapies and increase capacity"
  ],
  "editors_take": "Multiply Labs' funding round signals a shift towards automated pharmaceutical manufacturing, allowing the company to expand its robotic technology to more therapies and increase production capacity.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}